Oventus Medical Ltd or the Company (ASX: OVN) is pleased to announce that it has signed two additional contracts in the US sleep market with clinics that will provide Oventus devices for the treatment of Obstructive Sleep Apnoea (OSA) to patients. The first Californian lab in lab agreement has been signed with the prestigious Californian Center for Sleep Disorders, one of the US’ premier sleep centres, led clinically by leading sleep physician and Oventus Medical Technology Advisory Board member, Dr Jerrold Kram.
For more information, download the attached PDF.
Download this document